23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter ...

The DNA-testing company is exploring its options, including a business combination and the sale of some or all of its assets.

A pioneer in genetic heritage services, 23andMe has seen much of its share price wiped out in the past year as it struggles ...

By the 2023 fiscal year, 23andMe had reported a net loss of $312 million and its individual share price has plummeted a ...

23andMe Holding Co. ( ME, Financials) announced that its board's Special Committee is reviewing strategic alternatives, ...

Reports Q3 revenue $60.3M vs. $44.75M last yearInvest with Confidence: Follow TipRanks' Top Wall Street Analysts to uncover their success rate ...

The Special Committee of the Board of Directors of 23andMe Holding Co. (Nasdaq: ME) ("23andMe" or the "Company"), a leading human genetics company ...

Manhattan Associates' 2025 outlook missed estimates. The provider of supply-chain and omnichannel-commerce solutions said it expects adjusted per-share earnings of $4.45 to $4.55 on revenue of $1.06 ...

Are you also related to Charlemagne, described as 'one of the most important people in history'? Well, according to scientists, it's not difficult to find out.

Advances in DNA technology in the past three decades led Everett police to a Las Vegas man who was Maryann Daniels' neighbor when she was killed in 1989.

They did 23andMe a few years after my siblings and I did. One cousin showed up as a half-sibling, one showed up as a ...

Genetic testing firm 23andMe (NASDAQ:ME) said it formed a special board committee to review strategic alternatives. The special committee will look at options including a sale, business combination, ...